01.31.24
Merger challenges in pharmaceuticals, medtech and devices received a lot of attention and resources at the Federal Trade Commission (FTC) and State Attorneys General in 2023.
01.29.24
Antitrust enforcement in health care remained a high priority for the enforcers at the U.S. Department of Justice Antitrust Division and the Federal Trade Commission in 2023.
10.05.23
More hospital acquisitions may seek to avoid premerger scrutiny of the Federal Trade Commission (FTC) under the HSR Act (or any antitrust inquiry ever) if a recent federal district court decision holds up and becomes settled law.
09.26.23
No-poach agreements, wherein companies agree not to solicit or hire employees away from a competitor, have been targeted by the White House, the Federal Trade Commission and the Antitrust Division.